Analysis
| Earnings estimate |
Current quarter (Jan 2026) |
Next quarter (Apr 2026) |
Current year (Jul 2026) |
Next year (Jul 2027) |
|---|---|---|---|---|
| Number of analysts | 20 | 19 | 24 | 24 |
| Average estimate | 1.02 | 1.03 | 4.12 | 4.47 |
| Low estimate | 1.01 | 1.01 | 4.07 | 4.32 |
| High estimate | 1.03 | 1.05 | 4.23 | 4.64 |
| Last year EPS | 0.94 | 0.96 | 3.81 | 4.12 |
| Revenue estimate |
Current quarter (Jan 2026) |
Next quarter (Apr 2026) |
Current year (Jul 2026) |
Next year (Jul 2027) |
|---|---|---|---|---|
| Number of Analysts | 18 | 17 | 23 | 24 |
| Avg. estimate | 15.12B | 15.19B | 60.73B | 63.84B |
| Low estimate | 15.04B | 15.10B | 60.26B | 62.73B |
| High estimate | 15.19B | 15.32B | 61.27B | 65.44B |
| Last year sales | 13.99B | 14.15B | 56.65B | 60.73B |
| Sales growth | 0.08 | 0.07 | 0.07 | 0.05 |
| EPS trend |
Current quarter (Jan 2026) |
Next quarter (Apr 2026) |
Current year (Jul 2026) |
Next year (Jul 2027) |
|---|---|---|---|---|
| Current estimate | 1.02 | 1.03 | 4.12 | 4.47 |
| 7 days ago | 0.99 | 1.02 | 4.04 | 4.36 |
| 30 days ago | 0.99 | 1.02 | 4.04 | 4.36 |
| 60 days ago | 0.99 | 1.01 | 4.04 | 4.36 |
| 90 days ago | 1.00 | 1.01 | 4.04 | 4.36 |
| EPS revisions |
Current quarter (Jan 2026) |
Next quarter (Apr 2026) |
Current year (Jul 2026) |
Next year (Jul 2027) |
|---|---|---|---|---|
| Up last 7 days | 13 | 11 | 18 | 17 |
| Up last 30 days | 13 | 11 | 18 | 17 |
| Down last 7 days | 0 | 0 | 0 | 0 |
| Down last 30 days | 0 | 1 | 0 | 0 |
| Growth estimates | |
|---|---|
| Current qtr (Nov 2025) | 0.086% |
| Next qtr. (Feb 2026) | 0.072% |
| Current year (2025) | 0.081% |
| Next 5 years (per annum) | 0.076% |
| Past 5 years (per annum) | 0.056% |
Recommendation
Buy